Revolutionizing Targeted Cancer Therapy with Advanced Linkers
Discover the power of N-[6-(2,5-dihydro-2,5-dioxo-1H-pyrrol-1-yl)-1-oxohexyl]-L-valyl-N5-(aminocarbonyl)-N-[4-(hydroxymethyl)phenyl]-L-ornithinamide, a key component in next-generation Antibody-Drug Conjugates (ADCs). Unlock precision in cancer treatment.
Get a Quote & SampleProduct Core Value
![N-[6-(2,5-Dihydro-2,5-dioxo-1H-pyrrol-1-yl)-1-oxohexyl]-L-valyl-N5-(aminocarbonyl)-N-[4-(hydroxymeth](https://www.nbinno.com/webimg/gemini_6892de7b941a1_1754455675.png)
N-[6-(2,5-Dihydro-2,5-dioxo-1H-pyrrol-1-yl)-1-oxohexyl]-L-valyl-N5-(aminocarbonyl)-N-[4-(hydroxymethyl)phenyl]-L-ornithinamide
As a leading supplier in China, we offer N-[6-(2,5-dihydro-2,5-dioxo-1H-pyrrol-1-yl)-1-oxohexyl]-L-valyl-N5-(aminocarbonyl)-N-[4-(hydroxymethyl)phenyl]-L-ornithinamide, a highly specialized linker crucial for Antibody-Drug Conjugate (ADC) development. This compound is instrumental in creating targeted therapies that deliver potent cytotoxic payloads directly to cancer cells, minimizing damage to healthy tissues. Our commitment as a manufacturer in China ensures high purity and consistent quality for your critical research needs.
- Leveraging advanced peptide linker technology for Antibody-Drug Conjugates (ADCs): This compound is engineered for specific cleavage by enzymes like Cathepsin B, ensuring precise drug release within the tumor microenvironment.
- Enabling precise drug delivery systems: Utilize this critical component to build sophisticated drug delivery systems that enhance therapeutic efficacy and reduce systemic toxicity in oncology treatments.
- High purity pharmaceutical intermediates: As a trusted manufacturer in China, we guarantee a purity of 99%, making this a reliable choice for pharmaceutical research and development.
- Facilitating targeted cancer therapy innovation: Explore the potential of this linker to advance your work in developing novel treatments for various cancers through precise conjugation strategies.
Advantages of Using Our Product
Enhanced Therapeutic Efficacy
Our peptide linker plays a pivotal role in advancing targeted cancer therapy by facilitating the precise delivery of cytotoxic agents, a key aspect of effective drug delivery systems.
Biocompatibility and Specificity
Designed for enzymatic cleavage within the tumor, this linker ensures that the drug payload is released specifically at the target site, supporting the development of safer ADCs.
Reliable Supply Chain
As a reputable manufacturer in China, we provide a stable and reliable supply of this essential pharmaceutical intermediate, supporting your ongoing research and production needs.
Key Applications
Antibody-Drug Conjugate (ADC) Development
This linker is a cornerstone for synthesizing advanced ADCs, offering a cleavable mechanism for targeted payload delivery in cancer treatment research.
Targeted Drug Delivery Systems
Its specific cleavage properties make it ideal for engineering sophisticated drug delivery systems that concentrate therapeutic agents within tumor cells.
Oncology Research and Development
Researchers utilize this pharmaceutical intermediate to explore novel treatment modalities and improve the efficacy of chemotherapy and other anti-cancer strategies.
Bioconjugation Chemistry
The compound is essential in bioconjugation processes, enabling the precise attachment of drugs to antibodies or other targeting molecules.